A Week That Upends the Value Hierarchy

The Nasdaq had gained more than 2% through Wednesday. It then gave up 1.4% on Thursday, then nearly 3% on Friday (-2.87% in the final session). The tally comes to -2% for the week and -5.3% for October. Meanwhile, the Dow Jones is up 1.7% for the month, and healthcare was the best sector of the week. This contrast looks like a shift of capital rather than a simple correction.

Two Drivers: The Cost of Money and the Price of AI

The first is monetary. The Federal Reserve held rates steady on Wednesday, but its chair Kevin Warsh delivered a firm message on inflation and hinted that another hike was only a matter of time. The market expects one in December. Yet the financing of the AI race rests partly on debt: higher rates weigh directly on the profitability of these projects.

The second driver lies in quarterly results. Alphabet lost about 12% on Thursday after results below expectations and negative free cash flow. Intel dropped more than 28% on Friday, punished for weak guidance. Microsoft, whose Azure grows 48% with capital spending below forecasts, slipped only 0.5% for the week. Investors now pay for financial discipline rather than spending.

Capital Seeking Shelter, but Not Immunity

Eli Lilly, buoyed by demand for its obesity and diabetes treatments, gained more than 11% for the week and hit a record. FedEx Freight posted the best performance in the tracked basket. Yet the decline was broad-based. The Russell 2000 fell 1.65% and Canada's TSX 1.73%. In Asia, the KOSPI dropped 3.58% and the Nikkei 225 2.00%, two markets heavily exposed to semiconductors. The Euro Stoxx 50 lost 1.22% and the DAX 0.90%. Only the Hang Seng (+1.46%) and, more modestly, the Swiss SMI (+0.19%) held up.

The Limits of the Reading

The Dow Jones also closed lower in the final session (-1.09%): defensives cushion, they do not protect. The file contains no data on fund flows, bonds or currencies, so the rotation is inferred from relative sector performance. A December hike remains an expectation, and part of the declines is company-specific, such as the drop in demand for PC processors at Intel.

Key Takeaways

Markets appear to be repricing the risk attached to AI at a time when money could cost more. The shift toward healthcare and defensive stocks is consistent with the numbers, but its durability remains to be proven. The Fed's next decisions will settle the question.

This article was written with the assistance of artificial intelligence and verified by our editorial team.